PTK2 and ovarian cancer: Furthermore, in a mouse model of ovarian cancer, beta-adrenergic stimulation not only increased angiogenesis and tumor invasion through the cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) pathway [25], but also prevented the cancer cells from apoptosis by activating focal adhesion kinase (FAK) [28].